Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: Response to Neupane

Osteoporosis International

Volumn 25, Issue 3, 2014, Pages 1195-

  Prentice, R L ^a   Jackson, R D ^a   Pettinger, M ^a   Rossouw, J E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; CALCIUM CARBONATE; COLECALCIFEROL;

ADVERSE EFFECTS; DIET SUPPLEMENTATION; FEMALE; HUMAN; OSTEOPOROTIC FRACTURES;

BONE DENSITY CONSERVATION AGENTS; CALCIUM CARBONATE; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; OSTEOPOROTIC FRACTURES;

EID: 84894586095     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2461-z     Document Type: Letter

References (2)

1. Neupane S (2013) Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study. Osteoporos Int. doi: 10.1007/00198-013-2451-1
2. Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, LaCroix AZ, Anderson GA, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE (2013) Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int 24(2):567-580